Koers Pure Global Cannabis Inc. Toronto S.E.
Aandelen
PURE.H
CA74625A1075
Farmaceutische producten
Omzet 2017 | - | Omzet 2018 | - | Marktkapitalisatie | 24,16 mln. 33,26 mln. 22,47 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | - 0 0 | Nettowinst (verlies) 2018 | -23 mln. -31,66 mln. -21,39 mln. | EV/omzet 2017 * | - |
Nettoschuld 2017 | 211K 290K 196K | Nettoschuld 2018 | 4,49 mln. 6,18 mln. 4,18 mln. | EV/omzet 2018 | - |
K/w-verhouding 2017 * |
-
| K/w-verhouding 2018 |
-0,72
x | Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 83,64% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Vik Chopra
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sanjeev Goel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michael Lavergne
PRN | Corporate Officer/Principal | - | 30-07-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jane E. Pagel
BRD | Director/Board Member | - | 01-07-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+41,50% | 6,2 mld. | |
-22,89% | 4,1 mld. | |
+9,36% | 3,41 mld. | |
-19,39% | 2,83 mld. | |
-11,05% | 2,29 mld. | |
+45,24% | 1,93 mld. | |
-7,51% | 1,52 mld. | |
+46,81% | 1,51 mld. | |
-18,04% | 1,49 mld. |